An interventional study of Ultrasound scan in Endstage Renal Disease, sponsored by GE Healthcare. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-11-02.
Sponsored by GE Healthcare · Not applicable, Interventional, and Device feasibility
The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome.
The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome. All eligible adults (aged 18 or older) will contribute case data from a convenience sample of maintenance hemodialysis population available at the study site and consistent with feasibility assessment of the technology. A relatively large feasibility population is used due to the need to test feasibility of multiple features across variations within this population.
2,085 studies on the registry are indexed under Kidney Failure, Chronic; 260 are open to participants now.
This study's enrollment of 142 is above the median of 55 across 1,557 interventional studies indexed under Kidney Failure, Chronic.
Browse Kidney Failure, Chronic studies →GE Healthcare is the lead sponsor of 168 studies on the registry; 19 are open to participants now.
Of its 18 completed or terminated interventional studies of FDA-regulated products, 16 (89%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Eligible subjects in a convenience population at the site (Maintenance Hemodialysis, MHD) incidentally undergoingnon-invasive cardiac, pulmonary, and abdominal ultrasound scanning on the commercially available GE Vivid S70 system for use in testing feasibility of new algorithms for processing this data.
Device: Ultrasound scan
Collection of ultrasound data sets that include routine ultrasound data (eg, extravascular lung fluid, cardiac velocity time integral and inferior vena cava) on the commercial GE Vivid S70 Ultrasound System which are used to test feasibility of next generation ultrasound algorithms being developed to process these data types.
Number of Diagnostic Ultrasound Exams
Collection (number) of ultrasound images representative of sonographic findings routinely observed in the general imaging population.
Time frame: 1 day
| Milestone | MHD Population Ultrasound |
|---|---|
| Started | 142 |
| Completed | 142 |
| Not completed | 0 |
Collection (number) of ultrasound images representative of sonographic findings routinely observed in the general imaging population.
| Participants | MHD Population Ultrasound |
|---|---|
| Number of Diagnostic Ultrasound Exams | 142 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| MHD Population Ultrasound | 0/142 (0%) | 0/142 (0%) | 0/142 (0%) |
All enrolled subjects
| Age, Customized(Participants) | MHD Population Ultrasound |
|---|---|
| >=18 years | 142 |
| Sex/Gender, Customized(Participants) | MHD Population Ultrasound |
|---|---|
| Male or Female | 142 |
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
GE Healthcare